datetime,headline,summary,related,lang,source
2020-11-19 08:30:00-05:00,"CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020","ATLANTA, Nov. 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors and analysts to discuss progress with the Company's ongoing PROACT Xa trial on December 7,…",CRY,en,PR Newswire
2020-11-09 14:30:31-05:00,"Hemostats Market Leading Players | CryoLife, Inc., Gamma Therapeutics, Inc, Hemostasis, LLC, MedTrade Products Limited","Hemostats Market By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats , Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive",CRY,en,OpenPR
2020-11-06 07:17:14-05:00,"Heart Valve Market Is Thriving Worldwide |Colibri Heart Valve, Boston Scientific Corporation, Jenavalve Technology, St. Jude Medical, Cryolife, Symetis, Edwards Lifesciences, Livanova","New Study On Heart Valve Market: According to the ‘Market Growth Insight’, the Heart Valve market is anticipated to be estimated at USD XX billion along with CAGR of XX% over the forecast period 2020 - 2026. The Heart Valve study",CRY,en,OpenPR
2020-11-05 08:55:01-05:00,"Top Analyst Upgrades and Downgrades: Biogen, CryoLife, Honeywell, Microsoft, Ping, Qualcomm, Verizon, Wendy’s and More",No summary available.,CRY,en,24/7 Wall street
2020-11-05 08:55:01-05:00,"Top Analyst Upgrades and Downgrades: Biogen, CryoLife, Honeywell, Microsoft, Ping, Qualcomm, Verizon, Wendy’s and More – 24/7 Wall St.","Thursday's top analyst upgrades and downgrades included Biogen, CryoLife, Honeywell, Microsoft, Ping Identity, Qualcomm, Verizon Communications and Wendy's.",CRY,en,24/7 Wall street
2020-11-04 16:05:00-05:00,CryoLife Reports Third Quarter 2020 Financial Results,"ATLANTA, Nov. 4, 2020 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $65.1 million in the third quarter 2020 versus $67.9 million in the third quarter of 2019 Total revenues decreased 4% on a GAAP and non-GAAP constant currency basis versus third…",CRY,en,PR Newswire
2020-11-02 14:11:47-05:00,"Anastomosis Device Market 2020 Size & Share Analysis: Medtronic, Medical Devices Business Services, Inc., B. Braun Melsungen AG, EndoEvolution, LLC., CryoLife",Global Anastomosis Device Market research report has been organized with most up-to-date insight and analysis to give maximum benefits to the Healthcare industry. The report can be employed by both established and new players in the industry for complete understanding of,CRY,en,OpenPR
2020-10-26 07:43:45-05:00,"Surgical Sealants and Adhesives Market Top-Companies, Future-Growth, Regional Analysis, Business-Opportunities 2027 | Cohera Medical, CryoLife , C.R. Bard, CSL Limited, Johnson & Johnson","Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues, or even replace common suturing techniques. These products can be used as adjuncts to sutures to prevent air and liquid leakages. They can be developed","CSL,CRY",en,OpenPR
2020-10-21 07:04:00-05:00,CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results,"ATLANTA, Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results will be released on Wednesday, November 4, 2020 after the market closes. On that day, the…",CRY,en,PR Newswire
2020-10-20 05:50:06-05:00,"Surgical Sealants and Adhesives Market: Global Trends, Segmentation and Opportunities Forecast To 2027 | Baxter International Inc., Cohera Medical, Inc., CryoLife, Inc., Sanofi, Medtronic, Mallinckrodt Pharmaceuticals","The growth of the surgical sealants and adhesives market is driven by rise in geriatric population and increase in awareness towards the potential benefits of surgical sealants in surgical procedures. However, high cost associated with surgical sealants and the availability",CRY,en,OpenPR
2020-10-14 14:43:33-05:00,"Tissue Regeneration Market Future Scope By Isto Biologics (US), Athersys Inc. (US), Cerapedics, Inc. (US), co.don® AG. (US), Cook (US), CryoLife, Inc. (US) Cytori Therapeutics Inc. (US), Genzyme Corporation (US)","The market insights gained through this Tissue Regeneration Market research analysis report facilitates more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. With the meticulous competitor analysis covered in this",CRY,en,OpenPR
2020-08-06 07:35:00-05:00,CryoLife to Participate in Upcoming Virtual Investor Conferences,"ATLANTA, Aug. 6, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. CryoLife's management team will present at the upcoming…",CRY,en,PR Newswire
2020-07-30 15:05:00-05:00,CryoLife Reports Second Quarter 2020 Financial Results,"ATLANTA, July 30, 2020 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2020 versus $71.1 million in the second quarter of 2019 - Total revenues decreased 24% and decreased 23% on a non-GAAP constant currency…",CRY,en,PR Newswire
2020-07-21 16:00:00-05:00,CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results,"ATLANTA, July 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter financial results will be released on Thursday, July 30, 2020 after the market closes. On that day, the…",CRY,en,PR Newswire
2020-06-19 06:05:00-05:00,CryoLife Announces Pricing of $100 Million Convertible Senior Notes Offering,"ATLANTA, June 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) (""CryoLife"" or ""the Company""), a leading cardiac and vascular surgery company focused on aortic disease, today announced the pricing of $100 million aggregate principal amount of 4.250% convertible senior notes due 2025…",CRY,en,PR Newswire
2020-06-18 06:05:00-05:00,CryoLife Announces Offering of Convertible Senior Notes Due 2025,"ATLANTA , June 18, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY ) (""CryoLife"" or ""the Company""), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it intends to offer, subject to market conditions and other factors, $100,000,000 aggregate principal amount of convertible senior notes due 2025 (the ""Notes"") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the ""Securities Act""). CryoLife also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $15,000,000 aggregate principal amount of the Notes. The Notes will be senior unsecured obligations of the Company. The Notes are expected to pay interest semiannually and will mature on July 1, 2025 , unless earlier converted, redeemed or repurchased in accordance with their terms. Conversion of the Notes will be settled in cash, shares …",CRY,en,Benzinga Feeds
2020-06-11 08:57:00-05:00,"Insights on the Worldwide Surgical Sealant and Adhesives Industry to 2025 - Featuring Cohera Medical, CryoLife & Medtronic Among Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Surgical Sealant and Adhesives Market - Growth, Trends, and Forecasts (2020 - 2025)"" report has been added to ResearchAndMarkets.com's offering. Sealants and adhesives have been an integral part of the healthcare industry for a long time. They are a vital component in surgeries as they help the tissues to heal. Due to the rising prevalence of chronic diseases, the number of surgeries has increased worldwide. An increase in the number of surgeries has also boosted t",CRY,en,Business Wire
2020-06-10 20:40:00-05:00,COVID-19 Impact and Recovery Analysis- Aortic Stent Grafts Market 2020-2024 | Rising Preference for EVAR to Boost Growth | Technavio,"Technavio has been monitoring the aortic stent grafts market and it is poised to grow by USD 690.09 million during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200610005672/en/ Technavio has announced its latest market research report titled Global Aortic Stent Grafts Market 2020-2024 (Photo: Business Wire). Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Aortic Stent Grafts Market Download free sample report The market is concentrated, and the degree of concentration will accelerate during the forecast period.",CRY,en,Benzinga Feeds
2020-06-03 01:00:00-05:00,Global Structural Heart Disease Treatment Devices Market 2020-2024 | Increasing Structural Heart Diseases to Boost Growth | Technavio,"Technavio has been monitoring the global structural heart disease treatment devices market size and it is poised to grow by USD 5.61 billion during 2020-2024, progressing at a CAGR of over 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200602005571/en/ Technavio has announced its latest market research report titled Global Structural Heart Disease Treatment Devices Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Structural Heart Disease Treatment Devices Market Download free sample report The market is fragmented, and the degree of fragmentation will accelerate during the forecast period.",CRY,en,Benzinga Feeds
2020-04-30 18:25:06-05:00,"CryoLife (CRY) Reports Q1 Loss, Tops Revenue Estimates","CryoLife (CRY) delivered earnings and revenue surprises of -500.00% and 1.26%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",CRY,en,Zacks Investment Research
2020-04-30 15:05:00-05:00,CryoLife Reports First Quarter 2020 Financial Results,"ATLANTA, April 30, 2020 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 2020 versus preliminary first quarter 2020 revenues of $65.5 million Total revenues decreased 2% and decreased 1% on a constant currency…",CRY,en,PR Newswire
2020-02-27 16:05:00-05:00,CryoLife Receives CE Mark for On-X® Ascending Aortic Prosthesis,"ATLANTA, Feb. 27, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the On-X Ascending Aortic Prosthesis (AAP), allowing resumed distribution in the European Union. The…",CRY,en,PR Newswire
2020-02-13 16:05:00-05:00,CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results,"ATLANTA, Feb. 13, 2020 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Total revenues were $69.7 million in the fourth quarter of 2019, reflecting year over year growth of 3% and a 4% increase on a non-GAAP constant currency basis, both compared to the fourth quarter of…",CRY,en,PR Newswire
2020-01-30 08:34:00-05:00,CryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial Results,"ATLANTA, Jan. 30, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and year-end financial results will be released on Thursday, February 13, 2020 after the market closes. On…",CRY,en,PR Newswire
2019-12-19 08:30:00-05:00,CryoLife and Misonix Enter Into Distribution Agreement for NeoPatch,"ATLANTA, Dec. 19, 2019 /PRNewswire/ -- CryoLife, Inc. (""CryoLife""; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered into an agreement whereby Misonix (NASDAQ: MSON) will have exclusive US commercialization rights for…",CRY,en,PR Newswire
2019-12-16 05:59:23-05:00,Is Cryolife Inc (CRY) Going To Burn These Hedge Funds ?,Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an,CRY,en,Yahoo Finance
2019-12-02 08:02:00-05:00,CryoLife Receives CE Mark for E-nya Thoracic Stent Graft,"ATLANTA, Dec. 2, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending…",CRY,en,PR Newswire
2019-12-02 08:00:00-05:00,CryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent Graft,"ATLANTA, Dec. 2, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-nside TAAA multibranch stent graft system for the endovascular treatment of thoraco-abdominal…",CRY,en,PR Newswire
2019-10-30 15:05:00-05:00,CryoLife Reports Third Quarter 2019 Financial Results,"ATLANTA, Oct. 30, 2019 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5% and a 6% increase on a non-GAAP constant currency basis, both compared to the third quarter of 2018…",CRY,en,PR Newswire
2019-09-23 10:05:02-05:00,"Best Medical Equipment Stock Buy Now: CryoLife, Inc.","Experienced investment professionals who may be better informed than you now believe CryoLife, Inc. (CRY) to be the industry’s best near-term (3-month) capital",CRY,en,Seeking Alpha
2019-09-13 08:07:00-05:00,CryoLife Enters Agreement With Endospan for Aortic Stent,"CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.",CRY,en,Zacks Investment Research
2019-09-13 03:07:00-05:00,CryoLife Enters Agreement With Endospan for Aortic Stent,"CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.",CRY,en,Zacks Investment Research
2019-07-30 18:45:05-05:00,CryoLife (CRY) Surpasses Q2 Earnings and Revenue Estimates,"CryoLife (CRY) delivered earnings and revenue surprises of 37.50% and 0.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",CRY,en,Zacks Investment Research
2019-07-23 09:32:48-05:00,Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for,CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,CRY,en,Zacks Investment Research
2019-04-30 22:04:26-05:00,CryoLife (CRY) Q1 2019 Earnings Call Transcript -- The Motley Fool,"CRY earnings call for the period ending March 31, 2019.",CRY,en,The Motley Fool
2019-04-30 21:08:07-05:00,CryoLife's (CRY) CEO Patrick Mackin on Q1 2019 Results - Earnings Call Transcript,No summary available.,CRY,en,Seeking Alpha
2019-04-30 15:42:17-05:00,"CryoLife EPS in-line, beats on revenue",No summary available.,CRY,en,Seeking Alpha
2019-04-14 22:22:46-05:00,"Improve Your Chances Of Stock Investment Profit With Cryolife, Inc.","And learn how to do the same with dozens of other stocks, using similar insights and performance expectations records. Cryolife, Inc. today has nearly all the n",CRY,en,Seeking Alpha
2019-04-07 06:37:15-05:00,Disney+ And Bank Majors Step Out (Stocks To Watch Podcast),No summary available.,CRY,en,Seeking Alpha
